Exhibit 076 ยท Journalism
Merck Form 10-Q for the quarter ended 30 June 2026 (Gardasil litigation)
Merck's quarterly report states that the Gardasil settlement agreement was first entered in October 2025 and that its conditions were met by the filing date. It gives no dollar amount or case count and describes the total payment as considerably less than Merck's anticipated costs of defense and not material to Merck. It states that the March 2025 preemption ruling covered 16 bellwether cases and that plaintiffs appealed to the Fourth Circuit. A Bloomberg headline of 4 June 2026 reported that Merck would settle the bulk of Gardasil suits for about $50 million; the figure is not in Merck's filing.
- Source
- Bloomberg News
- Date
- August 2026
- Grade
- Reported
- Document
- https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/mrk-20260630.htm
- Accessed
- 2026-11-09
- Cited by
- Findings citing this exhibit
- Note
- The $50 million and 200-case figures remain press-reported only.